The SPRINT trial had to be prematurely terminated after recruiting 1358 patients because the use of nifedipine increased mortality following acute myocardial infarction.
Patients were randomised within 48 hr of a myocardial infarction to:
Mortality at 6 months in the placebo group was 13.3% compared to 15.4% in the nifedipine group.
The conclusion is that routine use of calcium channel blockers following myocardial infarction should be avoided.
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.